Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use QINLOCK safely and effectively. See full prescribing information for QINLOCK. QINLOCK® (ripretinib) tablets, for oral useInitial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
QINLOCK is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
- generic_name
- ripretinib
- product_names
- Ripretinib
- ndc
- 73207-101, 73207-101-30, 73207-101-31
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en